Status:

TERMINATED

Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus

Lead Sponsor:

Emory University

Collaborating Sponsors:

Dermatology Foundation

Conditions:

Cutaneous Lupus Erythematosus

Eligibility:

All Genders

18+ years

Phase:

PHASE2

Brief Summary

Lupus is a disease in which the immune system, which normally fights infection, begins to attack healthy cells in the body. This phenomenon is called autoimmunity and what the immune system attacks is...

Eligibility Criteria

Inclusion

  • i. Inclusion Criteria for observational arm:
  • Sites: Subjects will be primarily recruited from the Emory and Grady Memorial Hospital Dermatology Clinics. Additional recruitment will be from community dermatologists using a flyer since this is a relatively uncommon skin disease. This study will also be listed on the NIH and Lupus Foundation of America websites.
  • Stage of Disease: A previous or new diagnosis of CLE, either clinically supported or confirmed by skin biopsy.
  • Age: Adult subjects, greater than 18 years old.
  • ii. Inclusion criteria for control group in observational arm: Dermatology patients with skin disease, but without CLE, with skin types IV, V, VI will be recruited for the control group.
  • iii. Inclusion criteria for interventional arm: Patients with 25(OH)D levels \<30ng/ml.
  • iv. Exclusion Criteria:
  • Patients who are already actively having their vitD levels monitored and repleted.
  • Patients with 25(OH)D levels ≥30 ng/ml will be excluded from the RCT but are eligible for the observational arm of the study.
  • Patients with systemic lupus as defined by the American Rheumatism Association criteria.
  • Patients with renal lithiasis, hypercalcemia, inflammatory bowel disease, or sarcoidosis.
  • Pregnant patients.

Exclusion

    Key Trial Info

    Start Date :

    December 1 2011

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    June 1 2013

    Estimated Enrollment :

    3 Patients enrolled

    Trial Details

    Trial ID

    NCT01498406

    Start Date

    December 1 2011

    End Date

    June 1 2013

    Last Update

    November 20 2013

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Emory Dermatology Clinics

    Atlanta, Georgia, United States, 30322

    Vitamin D Status, Disease Specific and Quality of Life Outcomes in Patients With Cutaneous Lupus | DecenTrialz